Loading…

PB2319: ZUMA‐23: A GLOBAL, PHASE 3, RANDOMIZED CONTROLLED STUDY OF AXICABTAGENE CILOLEUCEL VERSUS STANDARD OF CARE AS FIRST‐LINE THERAPY IN PATIENTS WITH HIGH‐RISK LARGE B‐CELL LYMPHOMA

Saved in:

Bibliographic Details
Published in:	HemaSphere 2023-08, Vol.7 (S3), p.e3278692-n/a
Main Authors:	Westin, Jason, Jacobson, Caron, Chavez, Julio C, Sureda, Anna, Morschhauser, Franck, Glass, Bertram, Dickinson, Michael, Davies, Andrew J., Flinn, Ian W., Maloney, David, Chamuleau, Martine, Tees, Michael, Xue, Allen, Shahani, Shilpa, Nikolajeva, Olga, Kang, Janet, Kaplan, Aida, Schupp, Marco, Miao, Harry, Rich, Elizabeth Shima
Format:	Article
Language:	English
Subjects:	Publication Only
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!